ImmuneID Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Out of Business

  • Employees
  • 18

Employees

  • Latest Deal Type
  • Out of Business

ImmuneID General Information

Description

Developer of a medical proprietary platform intended to identify and therapeutically target antibody interactions that drive immune diseases. The company's platform is focused on employing parallel, multiplexed, and unbiased systems to develop therapeutics for autoimmunity, severe allergy, oncology, and infectious disease, enabling researchers to observe human immune responses throughout disease progression.

Contact Information

Website
www.immuneidrx.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 275 Second Avenue
  • Suite 100
  • Waltham, MA 02451
  • United States
+1 (617)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Life Sciences
Corporate Office
  • 275 Second Avenue
  • Suite 100
  • Waltham, MA 02451
  • United States
+1 (617)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ImmuneID Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 22-Nov-2024 Completed Out of Business
3. Secondary Transaction - Private 01-Nov-2023 Completed Generating Revenue
2. Early Stage VC (Series A) 28-Apr-2021 $50M $67.1M Completed Generating Revenue
1. Seed Round 13-Jan-2021 $17.1M $17.1M Completed Generating Revenue
To view ImmuneID’s complete valuation and funding history, request access »

ImmuneID Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A
Seed
To view ImmuneID’s complete cap table history, request access »

ImmuneID Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a medical proprietary platform intended to identify and therapeutically target antibody interactions that d
Biotechnology
Waltham, MA
18 As of 2023

Waltham, MA
 

Cambridge, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ImmuneID Competitors (4)

One of ImmuneID’s 4 competitors is Dragonfly (Biotechnology), a Venture Capital-Backed company based in Waltham, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Dragonfly (Biotechnology) Venture Capital-Backed Waltham, MA
HiFiBiO Therapeutics Venture Capital-Backed Cambridge, MA
CytomX Therapeutics Formerly VC-backed South San Francisco, CA
INmune Bio Formerly VC-backed Boca Raton, FL
To view ImmuneID’s complete competitors history, request access »

ImmuneID Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

ImmuneID FAQs

  • When was ImmuneID founded?

    ImmuneID was founded in 2020.

  • Where is ImmuneID headquartered?

    ImmuneID is headquartered in Waltham, MA.

  • What is the size of ImmuneID?

    ImmuneID has 18 total employees.

  • What industry is ImmuneID in?

    ImmuneID’s primary industry is Biotechnology.

  • Is ImmuneID a private or public company?

    ImmuneID is a Private company.

  • What is ImmuneID’s current revenue?

    The current revenue for ImmuneID is .

  • How much funding has ImmuneID raised over time?

    ImmuneID has raised $67.1M.

  • Who are ImmuneID’s competitors?

    Dragonfly (Biotechnology), HiFiBiO Therapeutics, CytomX Therapeutics, and INmune Bio are competitors of ImmuneID.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »